Navigation Links
Enhanced Gene Therapy Outcomes Following Latest Revolution And Refinement

Investigators and patients alike look forward to the day when it will be possible to correct the effects of abnormal genes by supplying the body with normal ones. Gene therapy refers to the treatment of a genetic disorder by inserting // normal genes into abnormal cells. The hope is that the transferred genes will cure the basic defect rather than merely alleviating its damage.

Getting sufficient amount of the normal gene to use in the treatment was not a stumbling block. Hundreds of human genes have been cloned by recombinant DNA techniques. The major problem is however putting the normal DNA into cells of the patient so that it can be integrated into the human body, followed by production of the required normal protein.

One approach towards gene therapy is the packing of the corrected gene material into a virus (Retrovirus) and then injecting it into the diseased cells. A new virus based gene therapy has been developed by Mayo Clinic research team to help fight cancer. The finding is expected to provide an answer to the hurdles existing regarding gene therapy for cancer.

The approach relies on particles called as "therapeutic hitchhikers”, derived from retroviruses (RNA-containing viruses that incorporate into the genomes of infected cells and then produce a therapeutic gene).

T cells are the immune system's major line of defense against tumors. The viral particles attach to a specific kind of T cell in the immune system and "hitchhike" to the tumor. By hitching a ride on the T cells, the therapeutic particles can hit their tumor target while avoiding detection (and destruction) by the immune system.

Experiments carried out on similar grounds in mice using human and mouse cancer cells, have been associated with significant cure rates of metastatic or spreading tumors. Autoimmune disorders or those with inflammation are other potential areas where the approach would be helpful.

"Our work is an imp ortant contribution to the maturation of the field of gene therapy because ultimately treating cancers by gene therapy depends on scientists' ability to specifically target tumor cells in the patient -- and this specific-delivery feature has eluded researchers for a variety of reasons. But by devising a way for viruses to hitch rides on antigen-specific T cells, we've been able to get over multiple obstacles to gene therapy”, according to the investigator.

The work is still at an experimental phase and has to undergo large scale refinement before it can be validated for human beings.
'"/>




Related medicine news :

1. Killing Power Of Bleach Enhanced By Addition Of Vinegar
2. PTSD Risk Enhanced With Mild Neurologic Deficits
3. Safety of Cancer Therapeutic Viruses Enhanced
4. Using Contrast Enhanced Sonography Improves Diagnosis of Liver and Spleen Injuries
5. Scientists Genetically Engineer Tomatoes With Enhanced Folate Content
6. Cancer Doctors Okays Controversial Prostate Therapy
7. Consensus on "Combination Therapy" for Breast Cancer
8. Gene Therapy shows promise in treating Hemophilia
9. "Make AIDS Therapy affordable" - Physicians demand
10. Hormone replacement Therapy a headache
11. Simple Therapy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... ... 2017 , ... Peruvian Ayahuasca retreat, East West Lodge, announced ... and divided between two full-time university students enrolled in U.S. or Canadian accredited ... apply for the scholarship, students are asked to submit an essay between 750 ...
(Date:7/24/2017)... ... ... The International Essential Tremor Foundation (IETF) will host a free educational forum in ... take place on Saturday, Aug. 26 at the Embassy Suites by Hilton Cleveland Rockside ... a.m. to 12 p.m., with check-in beginning at 8 a.m. The event is sponsored ...
(Date:7/24/2017)... ... , ... Every year, thousands of dedicated Higher Education and K12 professionals flock ... coupled with a dynamic theme like Camp Canvas; this year, they’ve managed to take ... , To extend their partnership with Canvas beyond the LMS integration, Modo Labs secured ...
(Date:7/24/2017)... CA (PRWEB) , ... July 24, 2017 , ... ... financial organizations, today announced it has partnered with WALLIX to expand its ... Publication 800-171 . , There are a number of ways to address the authentication ...
(Date:7/24/2017)... ... July 24, 2017 , ... The Topricin Companies, formerly Topical ... Topricin’s revolutionary, natural, after-burn skin care product, Topricin After Burn Cream. ... term skin conditions, including cancer. In the short term, overexposure to sun, ...
Breaking Medicine News(10 mins):
(Date:7/24/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) announced ... operating results on Monday, August 7, 2017 after market ... p.m. ET. Shareholders ... of the conference call by dialing 877-201-0168 or 647-788-4901 ... 15 minutes prior to the call. A live webcast ...
(Date:7/21/2017)... EDMONTON, Alberta , July 21, 2017  IBM ... of Alberta in Edmonton, Canada ... journal, Schizophrenia 1 , demonstrating that AI and ... with 74% accuracy. This retrospective analysis also showed ... in schizophrenia patients with significant correlation, based on ...
(Date:7/21/2017)... SPRING, Md. and RESEARCH TRIANGLE ... United Therapeutics Corporation (NASDAQ: UTHR ) announced ... financial results before the market opens on Thursday, July ... Therapeutics will host a teleconference on Thursday, July 27, ... accessible by dialing 1-877-351-5881, with international callers dialing 1-970-315-0533.  ...
Breaking Medicine Technology: